Trading halt to be lifted

Trading is expected to resume today for Pacific Edge shares after they were placed in a trading halt on Friday.

A statement to the market on Friday said the cancer diagnostics company became aware on Thursday night of the inclusion of Cxbladder CPT codes in a draft proposal for a different approach to determine which cancer biomarker tests were eligible for reimbursement by Novitas.

Pacific Edge would provide its shareholders with further clarification of the implications for the company once it had received advice from its US legal team and other advisers prior to lifting the trading halt.



Our journalists are your neighbours

We are the South's eyes and ears in crucial council meetings, at court hearings, on the sidelines of sporting events and on the frontline of breaking news.

As our region faces uncharted waters in the wake of a global pandemic, Otago Daily Times continues to bring you local stories that matter.

We employ local journalists and photographers to tell your stories, as other outlets cut local coverage in favour of stories told out of Auckland, Wellington and Christchurch.

You can help us continue to bring you local news you can trust by becoming a supporter.

Become a Supporter